バイオメディカル検査・分析サービス市場：技術、エンドユーザー、検査タイプ、サンプルタイプ別-2025～2030年世界予測

バイオメディカル検査・分析サービス市場は、2023年に31億7,000万米ドルと評価され、2024年には33億8,000万米ドルに達すると予測され、CAGR 7.94％で成長し、2030年には54億2,000万米ドルに達すると予測されています。

バイオメディカル検査・分析サービス市場は、疾病診断、治療モニタリング、先端研究を目的とした生物学的サンプルの分析を目的とした幅広い診断・分析サービスを包含しています。臨床上の意思決定を導き、治療レジメンの安全性と有効性を確保するために不可欠なデータを提供することで、医療において重要な役割を果たしています。主要用途には病理学、毒物学、遺伝子検査、臨床検査などがあり、エンドユーザーは病院、研究機関、製薬会社からバイオテクノロジー企業まで多岐にわたります。市場の成長は主に、慢性疾患の有病率の上昇、診断における自動化や人工知能などの技術進歩、個別化医療の重視の高まりに影響されています。さらに、COVID-19のパンデミックは、迅速かつ正確な検査ソリューションへの需要を加速させ、市場拡大に有利な機会を提供しています。注目すべきビジネス機会は、ポータブル診断ソリューションの開拓、新興国市場への進出、AI主導の分析ツールを革新するためのハイテク企業との協業にあります。

しかし、厳しい規制の枠組み、高度な診断技術に伴う高コスト、データのプライバシーやセキュリティに関する問題など、いくつかの限界や課題も残っています。さらに、熟練した専門家の不足や、既存の医療インフラに新技術を統合することの複雑さが、市場の成長を阻害する可能性もあります。非侵襲的検査法、リアルタイム・データ分析、バイオバンキングなどのセグメントでイノベーションを起こせば、大幅な事業成長の可能性があります。コストを削減しつつ、検査のスピードと精度を向上させるための調査が不可欠となります。規制要件の進化する状況に適応し、戦略的パートナーシップに注力することも、市場の成功を後押しする可能性があります。この市場の競合性を考慮すると、企業はデジタル技術の進歩を活用してサービス提供を改善し、顧客満足度を最大化する必要があります。市場の動向を予測し、既存の課題に積極的に対処することで、企業はこのダイナミックで急速に進化するセグメントで優位に立つことができます。

市場力学：急速に進化するバイオメディカル検査・分析サービス市場の主要市場洞察を公開

バイオメディカル検査・分析サービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 疾病の早期発見と個別化医療に対する需要の高まりが生物医療的検査市場を牽引
  • バイオメディカル検査サービスの精度と効率を高める技術と自動化の進歩
  • バイオメディカル検査サービスの成長に寄与する慢性疾患の有病率と高齢化率の上昇
  • 医薬品開発と疾患治療におけるゲノミクスとプロテオミクス研究の採用拡大が市場を後押し
• 市場抑制要因
  • バイオメディカル検査・分析サービスに対する厳格な規制要件とコンプライアンス基準の確保が困難
  • 生物医療研究施設における社内検査能力や高度な自動化システムとの激しい競合
• 市場機会
  • バイオテクノロジー企業と診断ラボの提携による技術革新の促進
  • 非侵襲的検査法への注目の高まりにより、医療スクリーニングの頻度と利用しやすさが向上
  • 生物医療検査・分析の進歩を支える規制状況と資金調達の機会
• 市場課題
  • バイオメディカル検査・分析サービスに関連するデータプライバシーとセキュリティへの懸念
  • 検査技師、バイオインフォマティクスの専門家、臨床研究者を含む熟練専門家の不足

ポーターの5つの力：バイオメディカル検査・分析サービス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオメディカル検査・分析サービス市場における外部からの影響の把握

外部マクロ環境要因は、バイオメディカル検査・分析サービス市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオメディカル検査・分析サービス市場における競合情勢の把握

バイオメディカル検査・分析サービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックスバイオメディカル検査・分析サービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオメディカル検査・分析サービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオメディカル検査・分析サービス市場における成功への道筋を描く

バイオメディカル検査・分析サービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 病気の早期発見と個別化治療の需要増加がバイオメディカル検査市場を牽引
    • 技術と自動化の進歩により、バイオメディカル検査サービスの精度と効率が向上
    • 慢性疾患の増加と人口の高齢化がバイオメディカル検査サービスの成長に寄与している
    • 医薬品開発や疾患治療におけるゲノミクスとプロテオミクス研究の採用増加が市場を活性化
  • 抑制要因
    • 生物医療的検査と分析サービスに対する厳格な規制要件とコンプライアンス基準を確保することの難しさ
    • バイオメディカル調査施設における社内検査機能と高度な自動化システムとの激しい競合
  • 機会
    • バイオテクノロジー企業と診断ラボの協力関係がイノベーションを加速
    • 非侵襲的検査方法に重点を置き、より頻繁でアクセスしやすい医療診断を推進する
    • バイオメディカル検査と分析の進歩を支える規制状況と資金調達の機会
  • 課題
    • バイオメディカル検査・分析サービスに関連するデータのプライバシーとセキュリティに関する懸念
    • 研究所技術者、バイオインフォマティクスの専門家、臨床研究者などの熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 バイオメディカル検査・分析サービス市場：技術別

• イントロダクション
• 細胞ベースの検査
  • 細胞生存率アッセイ
  • ハイコンテントスクリーニング
  • 生細胞イメージング
• 臨床化学
• 血液学
• 免疫測定
  • ELISA
  • 放射免疫測定
  • ウエスタンブロット
• 質量分析
  • メタボロミクス
  • プロテオミクス
• 微生物学的検査
• 分子診断
  • DNA配列分析
  • 等温核酸増幅
  • マイクロアレイ
  • PCR

第7章 バイオメディカル検査・分析サービス市場：エンドユーザー別

• イントロダクション
• バイオテクノロジーと製薬会社
• 診断ラボ
• 病院・クリニック
• 研究機関と学術センター

第8章 バイオメディカル検査・分析サービス市場：検査タイプ別

• イントロダクション
• 診断
• 予備検査
• 予後
• スクリーニング
• 治療モニタリング

第9章 バイオメディカル検査・分析サービス市場：サンプルタイプ別

• イントロダクション
• 血
• 脳脊髄液
• 唾液
• スツール
• 組織生検
• 尿

第10章 南北アメリカのバイオメディカル検査・分析サービス市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のバイオメディカル検査・分析サービス市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのバイオメディカル検査・分析サービス市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. BioIVT
• 2. BioReliance Corporation
• 3. Charles River Laboratories International, Inc.
• 4. Covance Inc.
• 5. Envigo
• 6. Eurofins Scientific
• 7. Frontage Laboratories, Inc.
• 8. ICON Central Laboratories
• 9. ICON plc
• 10. Inotiv, Inc.
• 11. IQVIA Holdings Inc.
• 12. Laboratory Corporation of America Holdings
• 13. Medpace Holdings, Inc.
• 14. Parexel International Corporation
• 15. Pharmaceutical Product Development, LLC
• 16. PPD, Inc.
• 17. PRA Health Sciences, Inc.
• 18. SGS SA
• 19. Syneos Health
• 20. WuXi AppTec

LIST OF FIGURES

• FIGURE 1. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL VIABILITY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY LIVE CELL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS & ACADEMIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PRELIMINARY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STOOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 74. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 76. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 77. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 78. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 79. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 80. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 81. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 118. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 119. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 120. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 121. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 122. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 123. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 124. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 126. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 127. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 128. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 129. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 130. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 131. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 134. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 142. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 143. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 145. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 148. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 150. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 151. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 152. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 153. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 154. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 158. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 159. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 160. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 161. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 162. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 163. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 166. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 167. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 168. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 169. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 170. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 178. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 180. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 182. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 183. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 184. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 185. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 186. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 187. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 188. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 190. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 191. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 192. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 193. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 194. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 195. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 196. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 198. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 199. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 200. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 201. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 202. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 203. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 213. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 215. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 216. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 217. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 218. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 219. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 220. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 223. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 224. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 225. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 226. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 227. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 228. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 229. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 231. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 232. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 233. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 234. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 235. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 236. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 237. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 239. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 240. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 241. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 242. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 243. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 244. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 245. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 246. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 247. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 248. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 249. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 250. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 251. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 252. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 253. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 254. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 255. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 256. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 257. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 258. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 259. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 260. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 261. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 262. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 263. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 264. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 265. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 266. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 267. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 268. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 269. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 271. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 272. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 273. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 274. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 275. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 276. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 277. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 278. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
• TABLE 279. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
• TABLE 280. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
• TABLE 281. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 282. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 283. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 284. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 285. NORWAY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 286. NORWAY BIOMEDICAL TESTING & ANALYSIS SERVICES MARK

The Biomedical Testing & Analysis Services Market was valued at USD 3.17 billion in 2023, expected to reach USD 3.38 billion in 2024, and is projected to grow at a CAGR of 7.94%, to USD 5.42 billion by 2030.

The Biomedical Testing & Analysis Services market encompasses a broad range of diagnostic and analytical services aimed at analyzing biological samples for disease diagnosis, therapeutic monitoring, and advanced research purposes. It plays a critical role in healthcare by providing essential data that guides clinical decision-making and ensures the safety and efficacy of treatment regimens. Key applications include pathology, toxicology, genetic testing, and clinical trials, with end-users ranging from hospitals, research institutes, and pharmaceutical companies to biotechnology firms. The market's growth is primarily influenced by the rising prevalence of chronic diseases, technological advancements such as automation and artificial intelligence in diagnostics, and the increasing emphasis on personalized medicine. Furthermore, the COVID-19 pandemic has accelerated the demand for rapid and accurate testing solutions, providing lucrative opportunities for market expansion. Noteworthy opportunities lie in the development of portable diagnostic solutions, expansion into emerging markets, and collaboration with tech companies to innovate AI-driven analytical tools.

However, some limitations and challenges persist, such as stringent regulatory frameworks, high costs associated with advanced diagnostic technologies, and issues related to data privacy and security. Additionally, market growth could be hindered by a shortage of skilled professionals and the complexities of integrating new technologies within existing healthcare infrastructures. Innovating in areas like non-invasive testing methods, real-time data analytics, and biobanking could offer substantial business growth potential. Research into enhancing test speed and accuracy, while reducing costs, will be essential. Adapting to the evolving landscape of regulatory requirements and focusing on strategic partnerships can also drive market success. Considering the competitive nature of this market, companies should leverage advancements in digital technology to improve service delivery and maximize customer satisfaction. By anticipating market trends and addressing existing challenges proactively, businesses can stay ahead in this dynamic and rapidly evolving sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomedical Testing & Analysis Services Market

The Biomedical Testing & Analysis Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
  • Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
  • Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
  • Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
• Market Restraints
  • Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
  • Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
• Market Opportunities
  • Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
  • Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
  • Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
• Market Challenges
  • Data privacy and security concerns associated with biomedical testing & analysis services
  • Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher

Porter's Five Forces: A Strategic Tool for Navigating the Biomedical Testing & Analysis Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomedical Testing & Analysis Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomedical Testing & Analysis Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomedical Testing & Analysis Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomedical Testing & Analysis Services Market

A detailed market share analysis in the Biomedical Testing & Analysis Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomedical Testing & Analysis Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomedical Testing & Analysis Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomedical Testing & Analysis Services Market

A strategic analysis of the Biomedical Testing & Analysis Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomedical Testing & Analysis Services Market, highlighting leading vendors and their innovative profiles. These include BioIVT, BioReliance Corporation, Charles River Laboratories International, Inc., Covance Inc., Envigo, Eurofins Scientific, Frontage Laboratories, Inc., ICON Central Laboratories, ICON plc, Inotiv, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Medpace Holdings, Inc., Parexel International Corporation, Pharmaceutical Product Development, LLC, PPD, Inc., PRA Health Sciences, Inc., SGS SA, Syneos Health, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Biomedical Testing & Analysis Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Cell-Based Tests, Clinical Chemistry, Hematology, Immunoassays, Mass Spectrometry, Microbiological Testing, and Molecular Diagnostics. The Cell-Based Tests is further studied across Cell Viability Assays, High Content Screening, and Live Cell Imaging. The Immunoassays is further studied across ELISA, Radioimmunoassay, and Western Blot. The Mass Spectrometry is further studied across Metabolomics and Proteomics. The Molecular Diagnostics is further studied across DNA Sequencing, Isothermal Nucleic Acid Amplification, Microarray, and PCR.
• Based on End Users, market is studied across Biotechnology & Pharmaceutical Companies, Diagnostic Laboratories, Hospitals & Clinics, and Research Institutions & Academic Centers.
• Based on Test Type, market is studied across Diagnostic, Preliminary Testing, Prognostic, Screening, and Therapeutic Monitoring.
• Based on Sample Type, market is studied across Blood, Cerebrospinal Fluid, Saliva, Stool, Tissue Biopsy, and Urine.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
    • 5.1.1.2. Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
    • 5.1.1.3. Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
    • 5.1.1.4. Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
  • 5.1.2. Restraints
    • 5.1.2.1. Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
    • 5.1.2.2. Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
  • 5.1.3. Opportunities
    • 5.1.3.1. Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
    • 5.1.3.2. Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
    • 5.1.3.3. Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
  • 5.1.4. Challenges
    • 5.1.4.1. Data privacy and security concerns associated with biomedical testing & analysis services
    • 5.1.4.2. Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biomedical Testing & Analysis Services Market, by Technology

• 6.1. Introduction
• 6.2. Cell-Based Tests
  • 6.2.1. Cell Viability Assays
  • 6.2.2. High Content Screening
  • 6.2.3. Live Cell Imaging
• 6.3. Clinical Chemistry
• 6.4. Hematology
• 6.5. Immunoassays
  • 6.5.1. ELISA
  • 6.5.2. Radioimmunoassay
  • 6.5.3. Western Blot
• 6.6. Mass Spectrometry
  • 6.6.1. Metabolomics
  • 6.6.2. Proteomics
• 6.7. Microbiological Testing
• 6.8. Molecular Diagnostics
  • 6.8.1. DNA Sequencing
  • 6.8.2. Isothermal Nucleic Acid Amplification
  • 6.8.3. Microarray
  • 6.8.4. PCR

7. Biomedical Testing & Analysis Services Market, by End Users

• 7.1. Introduction
• 7.2. Biotechnology & Pharmaceutical Companies
• 7.3. Diagnostic Laboratories
• 7.4. Hospitals & Clinics
• 7.5. Research Institutions & Academic Centers

8. Biomedical Testing & Analysis Services Market, by Test Type

• 8.1. Introduction
• 8.2. Diagnostic
• 8.3. Preliminary Testing
• 8.4. Prognostic
• 8.5. Screening
• 8.6. Therapeutic Monitoring

9. Biomedical Testing & Analysis Services Market, by Sample Type

• 9.1. Introduction
• 9.2. Blood
• 9.3. Cerebrospinal Fluid
• 9.4. Saliva
• 9.5. Stool
• 9.6. Tissue Biopsy
• 9.7. Urine

10. Americas Biomedical Testing & Analysis Services Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biomedical Testing & Analysis Services Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biomedical Testing & Analysis Services Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BioIVT
• 2. BioReliance Corporation
• 3. Charles River Laboratories International, Inc.
• 4. Covance Inc.
• 5. Envigo
• 6. Eurofins Scientific
• 7. Frontage Laboratories, Inc.
• 8. ICON Central Laboratories
• 9. ICON plc
• 10. Inotiv, Inc.
• 11. IQVIA Holdings Inc.
• 12. Laboratory Corporation of America Holdings
• 13. Medpace Holdings, Inc.
• 14. Parexel International Corporation
• 15. Pharmaceutical Product Development, LLC
• 16. PPD, Inc.
• 17. PRA Health Sciences, Inc.
• 18. SGS SA
• 19. Syneos Health
• 20. WuXi AppTec